CIRM Trio Says Alquist Legislation Creates Unnecessary Jeopardy
Three top leaders of the California stem cell agency today said new legislation aimed at making it more accountable and ensuring affordable access to taxpayer-funded therapies would instead jeopardize the agency's accomplishments.
In a word, they said, the measure is unnecessary.
Their opposition was delivered in a five-page letter to Democratic state Se…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.